Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3
出版年份 2013 全文链接
标题
Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3
作者
关键词
-
出版物
JOURNAL OF VIRAL HEPATITIS
Volume 20, Issue 10, Pages 669-677
出版商
Wiley
发表日期
2013-09-09
DOI
10.1111/jvh.12168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on the Treatment of Patients With Non–Genotype 1 Hepatitis C Virus Infection
- (2012) Alessandra Mangia et al. CLINICAL INFECTIOUS DISEASES
- Clinical utility of interleukin-28B testing in patients with genotype 1
- (2012) Michelle Lai et al. HEPATOLOGY
- Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner
- (2012) Paul J. Clark et al. HEPATOLOGY
- Hepatitis C therapy in non-genotype 1 patients: the near future
- (2012) C. Wartelle-Bladou et al. JOURNAL OF VIRAL HEPATITIS
- Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
- (2011) Graham R. Foster et al. GASTROENTEROLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C
- (2011) Michael Manns et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
- (2011) G. Nkontchou et al. JOURNAL OF VIRAL HEPATITIS
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- (2011) Markus Cornberg et al. LIVER INTERNATIONAL
- Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
- (2010) Fabrizio Mecenate et al. BMC GASTROENTEROLOGY
- An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response
- (2010) Alessandra Mangia et al. GASTROENTEROLOGY
- Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy
- (2010) Stephen A. Harrison et al. HEPATOLOGY
- Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin
- (2010) Moises Diago et al. HEPATOLOGY
- 37 SUSTAINED VIROLOGIC RESPONSE (SVR) FOLLOWING RG7128 1500MG BID/PEG-IFN/RBV FOR 28 DAYS IN HCV GENOTYPE 2/3 PRIOR NON-RESPONDERS
- (2010) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
- (2010) Alessandra Mangia et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
- (2010) Michael W. Fried et al. JOURNAL OF HEPATOLOGY
- Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up
- (2009) Kathleen E. Corey et al. HEPATOLOGY
- Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
- (2009) Pierre-Yves Bochud et al. JOURNAL OF HEPATOLOGY
- Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
- (2009) P. Gastaminza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
- (2008) Martin Lagging et al. HEPATOLOGY
- Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C
- (2007) Matteo Vidali et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More